Hormonal status in patients with advanced prostatic cancer on the therapy with androgen blockade | Zendy

Saša Vojinov | Zendy; I. Levakov | Zendy; Dimitrije Jeremić | Zendy; S. Zivojinov | Zendy; G. Marusic | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Hormonal status in patients with advanced prostatic cancer on the therapy with androgen blockade

Author(s) -

Saša Vojinov,

I. Levakov,

Dimitrije Jeremić,

S. Zivojinov,

G. Marusic

Publication year - 2011

Publication title -

vojnosanitetski pregled

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.123

H-Index - 19

eISSN - 2406-0720

pISSN - 0042-8450

DOI - 10.2298/vsp1104321v

Subject(s) - medicine , testosterone (patch) , luteinizing hormone , urology , prostate cancer , androgen , antiandrogen , blockade , hormone , hormonal therapy , flutamide , cancer , hyperplasia , endocrinology , androgen receptor , receptor

Hormone suppression therapy is used in men with advanced prostate cancer improving chances of longer survival. The aim of this study was to investigate the influence of androgen blockades on testosterone and luteinizing hormone (LH) values in patients with locally advanced and metastatic prostatic cancer.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research